4.7 Article

Lactiplantibacillus plantarum DSM20174 Attenuates the Progression of Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota, Improving Metabolic Risk Factors, and Attenuating Adipose Inflammation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Microbiology

Effects of caloric restriction on the gut microbiome are linked with immune senescence

Julia Sbierski-Kind et al.

Summary: Caloric restriction can improve metabolic health, reduce body fat accumulation, and enhance glucose tolerance, while delaying immune senescence by reducing specific cellular immune responses. This suggests that modulation of the gut microbiome could lead to the development of new therapeutic options for metabolic diseases.

MICROBIOME (2022)

Review Surgery

Mechanisms of nonalcoholic fatty liver disease and implications for surgery

Benedikt Kaufmann et al.

Summary: NAFLD has become the most common form of chronic liver disease worldwide, with various mechanisms leading to progression from steatosis to more severe forms. Preoperative diagnosis and peri-/postoperative management are essential for NAFLD patients with coexisting metabolic comorbidities.

LANGENBECKS ARCHIVES OF SURGERY (2021)

Review Oncology

Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular Carcinoma

Moritz Peiseler et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) is a prevalent chronic liver disease with a wide spectrum of severity, from simple steatosis to nonalcoholic steatohepatitis (NASH) and the risk of hepatocellular carcinoma (HCC). Inflammation plays a crucial role in the progression of the disease, involving a variety of immune cells within the liver, which also contribute to the development and potentially suppression of liver cancer. Advanced immunological studies have shed light on the complex mechanisms behind NAFLD pathogenesis and offer new therapeutic approaches towards preventing or treating NAFLD-related HCC.

CANCERS (2021)

Article Biochemistry & Molecular Biology

Effects of three different mannans on obesity and gut microbiota in high-fat diet-fed C57BL/6J mice

Yajian Song et al.

Summary: The study compared the effects of three mannans on obesity and obesity-related metabolic disorders in mice fed with a high-fat diet, showing that Konjac glucomannan (KGM), guar gum (GG), and locust bean gum (LBG) all had potential as alternative dietary supplements. However, the effects varied based on dosage and time, and the ability of mannans to regulate the gut microbiota played a crucial role in their functions. Analysis of gut microbiota sequencing revealed specific changes in abundance of certain OTUs, indicating a correlation with obesity and metabolic disorders.

FOOD & FUNCTION (2021)

Review Biochemistry & Molecular Biology

Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates

Ashiq Khan et al.

Summary: NAFLD is a leading chronic liver syndrome globally, with gut microbiota dysbiosis significantly affecting its pathogenesis and severity. Probiotics show promising effects in alleviating gut microbiota dysbiosis and inhibiting the progression of NAFLD through the gut-liver axis.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Review Gastroenterology & Hepatology

The gut-liver axis in liver disease: Pathophysiological basis for therapy

Agustin Albillos et al.

JOURNAL OF HEPATOLOGY (2020)

Article Biochemical Research Methods

Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data

Jasmine Chong et al.

NATURE PROTOCOLS (2020)

Article Medicine, General & Internal

Distinct differences in gut microbial composition and functional potential from lean to morbidly obese subjects

A. S. Meijnikman et al.

JOURNAL OF INTERNAL MEDICINE (2020)

Review Endocrinology & Metabolism

NAFLD as a continuum: from obesity to metabolic syndrome and diabetes

Amelio F. Godoy-Matos et al.

DIABETOLOGY & METABOLIC SYNDROME (2020)

Review Cell Biology

Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?

Patricia Rada et al.

CELL DEATH & DISEASE (2020)

Article Biochemistry & Molecular Biology

Nuciferine modulates the gut microbiota and prevents obesity in high-fat diet-fed rats

Yu Wang et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2020)

Review Biochemistry & Molecular Biology

Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease

Xiaoyan Li et al.

CELL AND BIOSCIENCE (2020)

Review Endocrinology & Metabolism

Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides

L. Korinkova et al.

FRONTIERS IN ENDOCRINOLOGY (2020)

Article Gastroenterology & Hepatology

Western Diet-Induced Adipose Inflammation Requires a Complex Gut Microbiota

Hao Q. Tran et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2020)

Article Biotechnology & Applied Microbiology

Lactobacillus plantarum NA136 improves the non-alcoholic fatty liver disease by modulating the AMPK/Nrf2 pathway

Zijian Zhao et al.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2019)

Review Medicine, Research & Experimental

The role of the microbiome in NAFLD and NASH

Aleksandra A. Kolodziejczyk et al.

EMBO MOLECULAR MEDICINE (2019)

Review Gastroenterology & Hepatology

Triggering and resolution of inflammation in NASH

Susanne Schuster et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction

Kristien E. Bouter et al.

GASTROENTEROLOGY (2017)

Review Endocrinology & Metabolism

Macrophage functions in lean and obese adipose tissue

Dylan Thomas et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2017)

Article Endocrinology & Metabolism

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)

Elena Buzzetti et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2016)

Article Endocrinology & Metabolism

C-Peptide-Based Index Is More Related to Incident Type 2 Diabetes in Non-Diabetic Subjects than Insulin-Based Index

Jong-Dai Kim et al.

ENDOCRINOLOGY AND METABOLISM (2016)

Article Gastroenterology & Hepatology

Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease

Johannie du Plessis et al.

GASTROENTEROLOGY (2015)

Article Ecology

High-fat diet alters gut microbiota physiology in mice

Hannelore Daniel et al.

ISME JOURNAL (2014)

Article Microbiology

LotuS: an efficient and user-friendly OTU processing pipeline

Falk Hildebrand et al.

MICROBIOME (2014)

Review Gastroenterology & Hepatology

Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging

Jessica K. Dyson et al.

FRONTLINE GASTROENTEROLOGY (2014)